Dr. Margeaux E Snell, MD
Claim this profileSt. Joseph's Hospital and Medical Center
Studies Cognitive Impairment
Studies Mild Cognitive Impairment
2 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials Margeaux E Snell, MD is currently running
Lenalidomide
for Mild Cognitive Impairment
Accumulating evidence indicates that inflammation is prominent both in the blood and central nervous system (CNS) of Alzheimer's disease (AD) patients. These data suggest that systemic inflammation plays a crucial role in the cause and effects of AD neuropathology. Capitalizing on the experience from a previous clinical trial with thalidomide, here, the investigators hypothesize that modulating both systemic and CNS inflammation via the pleiotropic immunomodulator lenalidomide is a putative therapeutic intervention for AD if administered at a proper time window during the course of the disease.
Recruiting0 awards Phase 214 criteria
Sensory Stimulation
for Alzheimer's Disease
This trial is testing a device that uses light and sound to help patients with mild to moderate Alzheimer's disease. The goal is to see if this sensory stimulation can slow down the progression of the disease by improving brain function. This therapy has shown potential for application in the treatment of Alzheimer's disease.
Recruiting0 awards N/A1 criteria
More about Margeaux E Snell, MD
Clinical Trial Related4 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Margeaux E Snell, MD has experience with
- Lenalidomide
- Sensory Stimulation System (GS120) - Active
- Sensory Stimulation System (GS120) - Sham
Breakdown of trials Margeaux E Snell, MD has run
Cognitive Impairment
Mild Cognitive Impairment
Amyloid Plaque
Inflammation
Neurodegeneration
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Margeaux E Snell, MD specialize in?
Margeaux E Snell, MD focuses on Cognitive Impairment and Mild Cognitive Impairment. In particular, much of their work with Cognitive Impairment has involved treating patients, or patients who are undergoing treatment.
Is Margeaux E Snell, MD currently recruiting for clinical trials?
Yes, Margeaux E Snell, MD is currently recruiting for 2 clinical trials in Phoenix Arizona. If you're interested in participating, you should apply.
Are there any treatments that Margeaux E Snell, MD has studied deeply?
Yes, Margeaux E Snell, MD has studied treatments such as Lenalidomide, Sensory Stimulation System (GS120) - Active, Sensory Stimulation System (GS120) - Sham.
What is the best way to schedule an appointment with Margeaux E Snell, MD?
Apply for one of the trials that Margeaux E Snell, MD is conducting.
What is the office address of Margeaux E Snell, MD?
The office of Margeaux E Snell, MD is located at: St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013 United States. This is the address for their practice at the St. Joseph's Hospital and Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.